3D Global Biotech Inc. (TPEX:6808)

Market Cap	4.70B
Revenue (ttm)	55.15M
Net Income (ttm)	-29.41M
Shares Out	77.84M
EPS (ttm)	-0.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	506,009
Average Volume	622,012
Open	57.50
Previous Close	57.50
Day's Range	57.20 - 60.30
52-Week Range	26.90 - 73.50
Beta	0.39
RSI	53.95
Earnings Date	Mar 24, 2025

About 3D Global Biotech

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orth...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 33
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6808

Financial Performance

In 2023, 3D Global Biotech's revenue was 20.63 million, an increase of 51.24% compared to the previous year's 13.64 million. Losses were -57.95 million, -13.62% less than in 2022.